Abstract
The cytokines are protein mediators of inflammation and immunity. Within the last decade, numerous cytokine activities originally defined by a variety of biological assays have become increasingly well defined; thanks to laborious protein purification and ultimately the application of recombinant DNA technology. The availability of well defined proteins expressed using molecular biologic techniques has provided material for precise definition of the activities and targets for these various mediators. Several general findings have emerged from this effort. One principle is that a single molecule or family of related molecules may exhibit multiple activities previously considered unrelated. A corollary is that cytokines tend to occur in families of closely related isoforms or structurally or functionally related proteins. Despite these simplifying generalizations, the list of recognized cytokines continues to expand. There are now some nine different interleukins (IL), many different colony stimulating factors (CSFs) and several distinct interferon classes. There is also an intriguing degree of overlap between the structure and function of molecules generally considered cytokines and certain peptide growth factors. For example IL1-ß has regions of amino acid sequence similarity with members of the fibroblast growth factor (FGF) superfamilyl.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Thomas, K.A., Rios-Candelore, M., Gimenez-Gallego, G., DiSavlo, J., Bennett, C., Rodkey, J. and Fitzpatrick, S. 1985. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin I. Proc. Natl. Acad. Sci. USA82: 6409–6413.
Auron, P.E., Webb, A.C., Rosenwasser, L.J., Mucci, S.F., Rich, A., Wolff, S.M. and Dinarello, C.A. 1984. Nucleotide sequence of human monocyte interleukin-1 precursor cDNA. Proc. Natl. Acad. Sci. USA81: 7907–7911.
March, C.J., Mosley, B., Larsen, A., Cerretti, D.P., Braedt, G., Price, V., Gillis, S., Henney, C.S., Kronheim, S.R., Grabstein, K., Conlon, P.J., Hopp, T.P. and Cosman, D. 1985. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature (Lond.) 315: 641–647.
Gubler, U., Chua, O.A., Stern, A.S., Hellman, C.P., Vitek, M.P., Dechiara, T.M., Benjamin, W.R., Collier, K.J., Dukovich, M., Familetti, P.C., Fiedler-Nagy, C., Jenson, J., Kaffka, K., Kilian, P.L., Stremlo, D., Wittreich, B.H., Woehle, D., Mizel, S.B. and Lomedico, P.T. 1986. Recombinant human interleukin la: Purification and biological characterization. J. Immunol. 136: 2492–2497.
Dinarello, C.A. 1989. Interleukin 1 and its biologically related cytokines. Adv. Immunol. 144: 153–205.
Bevilacqua, M.P., Pober, J.S., Wheeler, M.E., Cotran, R.S., Gimbrone, M.A.J. 1985. Interleukin-1 activation of vascular endothelium effects on procoagulant activity and leukocyte adhesion. Am. J. Path. 121: 393–403.
Pober, J.S. and Cotran, R.S. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70: 427–451.
Wagner, C.R., Vetto, R.M., Burger, D.R. 1985. Expression of I-region-associated antigen (Ia) and interleukin 1 by subcultured human endothelial cells. Cell. Immunol. 93: 91–104.
Libby, P., Ordovds, J.M., Auger, K.R., Robbins, H., Birinyi, L.K. and Dinarello, C.A. 1986. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am. J. Path. 124: 179–186.
Nawroth, P.P., Bank, I., Handley, D., Cassimeris, J., Chess, L. and Stern, D. 1986. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. J. Exp. Med. 163: 1363–1375.
Kurt-Jones, E.A., Fiers, W. and Pober, J.S. 1987. Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J. Immunol. 139: 2317–2324.
Moyer, C.F. and Reinisch, C.L. 1984. The role of vascular smooth muscle cells in experimental autoimmune vasculitis. I. The initiation_of delayed type hypersensitivity angiitis. Am. J. Pathol. 117: 380–390.
Libby, P., Ordovàs, J.M., Birinyi, L.K., Auger, K.R. and Dinarello, C.A. 1986. Inducible interleukin-1 expression in human vascular smooth muscle cells. J. Clin. Invest. 78: 1432–1438.
Warner, S.J.C., Auger, K.R. and Libby, P. 1987. Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J. Exp. Med. 165: 1316–1331.
Fleet, J., Clinton, S., Salomon, R., Loppnow, H. and Libby, P. 1990. Atherogenic diets increase endotoxin-stimulated cytokine gene expression in rabbit aortae. FASEB J. 4: A1156.
Williams, K., Sajuthi, D., Tulli, H., Huggins, E. and Moyer, C. 1990. Vascular cells in atherosclerotic plaques of cynomolgous monkeys synthesize interleukin-1. FASEB J. 4: A1154.
Zilberstein, A., Ruggieri, R., Korn, J.H. and Revel, M. 1986. Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J. 5: 2529–2537.
Brakenhoff, J.P., de Groot, E.R., Evers, R.F., Pannekoek, H. and Aarden, L.A. 1987. Molecular cloning and expression of hybridoma growth factor in Escherichia coli. J.Immunol. 139: 4116–4121.
Sehgal, P.B., May, L.T., Tamm, I. and Vilcek, J. 1987. Human B2 interferon and B-cell differentiation factor BSF-2 are identical. Science 235: 731–732.
Wong, G.G. and Clark, S.C. 1988. Multiple actions of IL6 within a cytokine network. Immunol. Today 9: 137–139.
Van Damme, J. 1989. Biochemical and biological properties of human HPGH/IL-6. Annals N.Y. Acad. Sci. 557: 104–112.
Norioka, K., Hara, M., Harigai, M., Kitani, A., Hirose, T., Suzuki, K., Kawakami, M., Tabata, H., Kawagoe, M. and Nakamura, H. 1988. Production of B cell stimulatory factor-2/interleukin-6 activity by human endothelial cells. Biochem. Biophvs. Res. Comm. 153: 1045–1050.
Sironi, M., Breviario, F., Proserpio, P., Biondi, A., Vecchi, A., Van Damme, J., Dejana, E. and Mantovani A. 1989. IL1 stimulates IL6 production in endothelial cells. J. Immunol. 142: 549–553.
Jirik, F.R., Podor, T.J., Hirano, T., Kishimoto, T., Loskutoff, D.J., Carson, D.A. and Lotz, M. 1989. Bacterial lipopolysaccharides and inflammatory mediators augment IL6 secretion by human endothelial cells. J. Immunol. 142: 144–147.
Loppnow, H. and Libby, P. 1989. Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1. Cell. Immunol. 122: 493–503.
Loppnow, H. and Libby, P. 1990. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J. Clin. Invest. 85: 731–738.
Le, J.M. and Vilcek, J. 1989. Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest. 61: 588–602.
Le, J.M., Fredrickson, G., Pollack, M. and Vilcek, J. 1989. Activation of thymocytes and T cells by interleukin-6. Ann. N. Y. Acad. Sci. 557 : 444–452.
Warner, S.J.C. and Libby, P. 1989. Human vascular smooth muscle cells: Target for and source of tumor necrosis factor. J. Immunol. 142: 100–109.
Barath, P., Fishbein, M.C., Cao, J., Berenson, J., Helfant, R.H and Forrester, J.S. 1990. Detection and localization of tumor necrosis factor in human atheroma. Am. J. Cardiol. 65: 297–302.
Matsushima, K. and Oppenheim, J.J. 1989. Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL1 and TNF. Cvtokine 1: 2–13.
Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E.A., Appella, E., Oppenheim, J.J. and Leonard, E.J. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl. Acad. Sci. USA 84: 9233–9237.
Gimbrone, M.A. Jr., Obin, M.S., Brock, A.F., Luis, E.A., Hass, P.E., Hébert, C.A., Yip, Y.K., Leung, D.W., Lowe, D.G., Kohr, W.J., Darbonne, W.C., Bechtol, K.B. and Baker, J.B. 1989. Endothelial interleukin-8: A novel inhibitor of leukocyte-endothelial interactions. Science 246: 1601–1603.
Rollins, B.J., Morrison, E.D. and Stiles, S.C. 1988. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc. Natl. Acad. Sci. USA 85: 3738–3742.
Taubman, M.B., Rollins, B.J. and Nadal-Ginard, B. 1989. Expression of the JE gene in vascular smooth muscle cells: Differential effects of PDGF and angiotensin II. Circulation 80 (4): 11–451.
Metcalf, D. 1986. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 67: 257–267.
Clark, S.C. and Kamen, R. 1987. The human hematopoietic colony-stimulating factors. Science 236: 1229–1237.
Groopman, J.E., Molina, J.M. and Scadden, D.T. 1989. Hematopoietic growth factors. Biology and clinical applications. N EnRI J Med 321: 1449–1459.
Quesenberry, P.J. and Gimbrone, M.A. Jr. 1980. Vascular endothelium as a regulator of granulopoiesis: Production of colony-stimulating activity by cultured human endothelial cells. Blood 56: 1060–1067.
Bagby, G.C.J., Dinarello, C.A., Wallace, P., Wagner, C., Hefeneider, S. and McCall, E. 1986. Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells. J. Clin. Invest. 78: 1316–1323.
Bussolino, F., Wang, J.M., Defilippi, P., Turrini, F., Sanavio, F., S., E.C.-J., Aglietta, M., Arese, P. and Mantovani, A. 1989. Granulocyte-and granulocyte-macrophagecolony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337: 471–473.
Rajavashisth, T.B., Andalibi, A., Territo, M.C., Berliner, J.A., Navab, M., Fogelman, A.M. and Lusis, A.J. 1990. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins. Nature 344: 254–257.
Ross, R. 1986. The pathogenesis of atherosclerosis - an update. New Engl. J. Med. 314: 488–500.
Pestka, S., Langer, J.A., Zoon, K.C. and Samuel, C.E. 1987. Interferons and their actions. Ann. Rev. Biochem. 56: 727–777.
Warner, S.J.C., Friedman, G.B. and Libby, P. 1989. Immune interferon inhibits proliferation and induces 2’-5’-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. J. Clin. Invest. 83: 1174–1182.
Hansson, G.K., Jonasson, L., Holm, J., Clowes, M.K., Clowes, A. 1988. Gamma interferon regulates vascular smooth muscle proliferation and la expression in vivo and in vitro Circ. Research 712–719.
Benech, P., Mory, Y., Revel, M. and Chebath, J. 1985. Structure of two forms of the interferon-induced (2’-5’) oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J. 2249–2256.
Chebath, J., Benech, P., Mory, Y., Mallucci, L., Michalevicz, R. and Revel, M. 1986. IFN and (2’-5’) oligo A synthetase in cell growth and in differentiation of hematopoietic cells. 351–363.
Palmer, H.J. and Libby, P. 1990. Interferon-beta: A potential autocrine regulator of human vascular smooth muscle cell (SMC) proliferation. FASEB J. 4: A906.
Reis, L.F., Ho, L.T. and Vilcek, J. 1989. Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts. J. Biol. Chem. 264: 16351–16354.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Libby, P. et al. (1991). Production of Cytokines by Vascular Wall Cells: An Update and Implications for Atherogenesis. In: Gotlieb, A.I., Langille, B.L., Fedoroff, S. (eds) Atherosclerosis. Altschul Symposia Series, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3754-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3754-0_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6672-0
Online ISBN: 978-1-4615-3754-0
eBook Packages: Springer Book Archive